Onconetix
Price & Volume
Stats
See more52W Range | $1.37-$59.50 |
Market Cap | $2.7M |
Shares Short | 92,196 |
Financials
See moreRevenue (12 Mos) | $1.2M |
Revenue Growth (YoY) | -25.4% |
Gross Profit (12 Mos) | $1M |
Diluted EPS | $1,229.73 |
News
See moreYahoo Finance • 3 months ago
Onco-Innovations Announces Closing of Private Placement
Yahoo Finance • 4 months ago
Onconetix announces financing through private placement, debt settlement
Yahoo Finance • 4 months ago
Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc.
Yahoo Finance • 4 months ago
Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement
About
CEO | Ms. Karina M. Fedasz |
CFO | Ms. Karina M. Fedasz |
Address | 201 East Fifth Street, Cincinnati, OH, United States, 45202 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 5 |
